[1]
“The Impact of the COVID-19 Pandemic on Patients Diagnosed with Chronic Inflammatory Demyelinating Polyradiculoneuropathy – Three-Year Follow-Up”, JSMCR, vol. 2, no. 4, pp. 1–7, Oct. 2025, doi: 10.64142/jsmcr.2.4.51.